← Leaderboards
Travis W Hein
Scott And White Memorial Hospital
$5,597,670
Attributed
$6,326,764
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,326,764 · 5
By mechanism
R01$5,921,389 · 4
R21$405,375 · 1
Top collaborators
- Lih Kuo4 shared
Others in their field
Top investigators on “Family Suidae”
- David H Sachs · Columbia University Health Sciences$27,938,778
- David A Stoltz · University Of Iowa$23,917,771
- Jianyi Zhang · University Of Alabama At Birmingham$20,789,788
- Dafna Bar-Sagi · State University New York Stony Brook$19,477,294
- Devendra K. Agrawal · Creighton University$19,059,808
- Joseph Zabner · University Of Iowa$19,038,827
Research focus
Family SuidaeEndotheliumEventDiabetic RetinopathyBlood FlowBlood VesselsRetinaMolecularRegulationFunctional DisorderVasomotorRetinal DamageBlindnessProductionProteinsArterioleSignal TransductionLinkIschemiaNeuronsRetinal IschemiaMediatingOxygenRetinal
Grant awards (19)
Endothelin-1 System Activation and Retinal Microvascular Dysregulation during Early Diabetes$321,938
R01 · FY2025 · EY · contact PI
Endothelin-1 System Activation and Retinal Microvascular Dysregulation during Early Diabetes$378,750
R01 · FY2024 · EY · contact PI
Endothelin-1 System Activation and Retinal Microvascular Dysregulation during Early Diabetes$378,750
R01 · FY2023 · EY · contact PI
Endothelin-1 System Activation and Retinal Microvascular Dysregulation during Early Diabetes$378,750
R01 · FY2022 · EY · contact PI
Roles of LOX-1 and Stress-Activated Kinases in Retinal Dysfunction during Early Diabetes$462,420
R01 · FY2017 · EY · contact PI
Roles of LOX-1 and Stress-Activated Kinases in Retinal Dysfunction during Early Diabetes$462,420
R01 · FY2016 · EY · contact PI
Vasomotor Dysfunction of Retinal Arterioles in Diabetes$378,098
R01 · FY2016 · EY · contact PI
Intravitreal ECE-1 siRNA Treatment for Retinal Dysfunction during Early Diabetes$185,625
R21 · FY2016 · EY · contact PI
Roles of LOX-1 and Stress-Activated Kinases in Retinal Dysfunction during Early Diabetes$462,420
R01 · FY2015 · EY · contact PI
Vasomotor Dysfunction of Retinal Arterioles in Diabetes$370,536
R01 · FY2015 · EY · contact PI
Intravitreal ECE-1 siRNA Treatment for Retinal Dysfunction during Early Diabetes$219,750
R21 · FY2015 · EY · contact PI
Vasomotor Dysfunction of Retinal Arterioles in Diabetes$382,893
R01 · FY2014 · EY · contact PI
Role of Endothelin System and NAD(P)H Oxidase in Retinal Arteriolar Dysfunction$316,440
R01 · FY2012 · EY · contact PI
Role of Endothelin System and NAD(P)H Oxidase in Retinal Arteriolar Dysfunction$316,440
R01 · FY2011 · EY · contact PI
Role of Endothelin System and NAD(P)H Oxidase in Retinal Arteriolar Dysfunction$329,670
R01 · FY2010 · EY · contact PI
Role of Endothelin System and NAD(P)H Oxidase in Retinal Arteriolar Dysfunction$333,000
R01 · FY2009 · EY · contact PI
Role of Endothelin System and NAD(P)H Oxidase in Retinal Arteriolar Dysfunction$293,510
R01 · FY2009 · EY · contact PI
Role of Endothelin System and NAD(P)H Oxidase in Retinal Arteriolar Dysfunction$22,354
R01 · FY2009 · EY · contact PI
Role of Endothelin System and NAD(P)H Oxidase in Retinal Arteriolar Dysfunction$333,000
R01 · FY2008 · EY · contact PI